The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 724-725, October 2008

Are persons with asthma at increased risk of pneumococcal infections, and can we prevent them?

  • Tina V. Hartert, MD, MPH

      Affiliations

    • Corresponding Author InformationReprint requests: Tina V. Hartert, MD, MPH, Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Institute of Medicine and Public Health, Vanderbilt University School of Medicine, Nashville, TN 37232.

Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Institute of Medicine and Public Health, Vanderbilt University School of Medicine, Nashville, Tenn

Received 5 September 2008; accepted 5 September 2008.

Key words: Asthma, pneumococcal disease, pneumococcal vaccine, infection

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Adapted from a presentation by Tina V. Hartert at the American Academy of Asthma Allergy and Immunology National Institute of Allergy and Infectious Diseases Symposium, March 2008, “Atopy, Immune Regulation, and Infectious Diseases.”

 Disclosure of potential conflict of interest: T. V. Hartert is on the advisory board and speakers' bureau for Merck, has received research support from the National Institutes of Health and the Thrasher Research Fund, and has served as a member of the American Thoracic Society.

PII: S0091-6749(08)01669-2

doi:10.1016/j.jaci.2008.09.008

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 4 , Pages 724-725, October 2008

Article Tools